Drafting agreements in the biotechnology and pharmaceutical industries

This looseleaf provides precedent agreements and legal commentary in relation to the main types of commercial transaction encountered in the life-cycle of a product in the biotechnology and pharmaceutical industries.

Each agreement is accompanied by detailed commentary on legal, commercial and practice issues.

In addition the commentary highlights important differences between English law and other key EU jurisdictions comprising Germany, France, the Netherlands, Spain and Sweden with specific commentary being provided by specialist lawyers within these countries.

Further commentary on the US specific issues is provided in the first updating release.

The third part of the looseleaf incorporates a separate summary and discussion of legal issues that are common to different types of agreement, relevant statutory and legal materials and website links to other relevant materials. The looseleaf is published with an accompanying online resource providing plain versions of all the precedents which can be downloaded and edited to enable the user to create and amend precedents based on those provided by the work.